After the facial nerve axotomy (FNA), the distal end of the axon would gradually decay and disappear. Accumulated evidence shows that transplantation of bone marrow mesenchymal stem cells (BMSCs) reveals potential in the treatment of nervous system diseases or injuries. This study is aimed at investigating the therapeutic effects of co-transplantation of BMSCs and monocytes in FNA. We found that co-culture significantly elevated the CD4+/CD8+ ratio and CD4+ CD25+ T cell proportion compared with monocytes transplantation, and enhanced the differentiation of BMSCs into neurons. After the cell transplantation, the lowest apoptosis in the facial nerve nucleus was found in the co-transplantation group 2 (BMSCs:monocytes= 1:30). Moreover, the lowest expression levels of pro-inflammatory cytokines and the highest expression levels of anti-inflammatory cytokines were observed in the co-transplantation group 2 (BMSCs: monocytes= 1:30). The highest expression levels of protein in the JAK/STAT6 pathway and the SDF-1/CXCR4 axis were found in the co-transplantation group 2. BMSC/monocyte co-transplantation significantly improves the microenvironment in the facial nerve nucleus in FNA rats; therefore these findings suggest that it could promote the anti-/pro-inflammatory balance shift towards the anti-inflammatory microenvironment, alleviating survival conditions for BMSCs, regulating BMSC the chemotaxis homing, differentiation, and the section of BMSCs, and finally reducing the neuronal apoptosis. These findings might provide essential evidence for the in-hospital treatment of FNA with co-transplantation of BMSCs and monocytes.
16 May 2025 in The International Journal of Cardiovascular Imaging
Purpose: To develop a predictive model based on spectral CT-derived parameters for preoperative assessment of extramural venous invasion (EMVI) in patients with colon cancer. Methods: This retrospective study included 235 patients with pathologically confirmed colon cancer from two medical centers between September 2022 and July 2024 (192 from center 1 and 43 from center 2). Virtual monoenergetic images (VMIs) ranging from 40 to 120 keV (20 keV increments) were evaluated to identify the optimal energy level based on tumor CT value, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). On the optimal VMI, spectral CT quantitative parameters were measured in the arterial, venous, and delay phases, and dynamic multiphase parameters were calculated. Patients from center 1 were randomly divided into a training cohort and an internal testing cohort at a 7:3 ratio. The nomogram model was developed using the training cohort and subsequently evaluated in the internal testing cohort and an independent external validation cohort from center 2. Results: (1) The 60 keV VMI demonstrated superior image quality, showing significantly higher tumor CT value, SNR, and CNR compared with other monoenergetic images (all P < 0.05). (2) Compared with EMVI negative patients, positive patients exhibited significantly higher values of ΔHU40 (delay−arterial) , ΔHU60 (delay−arterial) , ΔIC (delay−arterial) , delay enhancement fraction (DEF), and ΔZeff (venous−arterial) (all P < 0.05). Multivariable analysis further identified these five parameters as independent predictors of EMVI. (3) A nomogram was constructed based on these parameters and demonstrated AUCs of 0.93, 0.91, and 0.84 in the training, testing, and external validation cohorts, respectively. Conclusions: The 60 keV VMI provides improved lesion delineation in colon cancer. A nomogram incorporating dynamic multiphase spectral CT parameters enables accurate preoperative prediction of EMVI and may support individualized clinical decision-making.